Post-Renovation BioPort Production
View Pre-Renovation Lots
FDA Lot-Release Authorizations
These memos show the authority for the manufacturer to release anthrax
vaccine from the manufacturing plant. Each lot of every vaccine produced in the
United States must be individually released in this way, after having been
tested for sterility, purity, potency, and general safety. Lot-release tests are
performed by the manufacturer and audited by FDA.
*For Anthrax vaccine released
after January 2002 (Lots FAV063 and higher).
|
|
 |
|
|
|
|
|